| BINOCRIT SANDOZ AG
1680792 11 Jun 2014 | on 11 Jul 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular systems, and for use in oncology; pharmaceutical preparations for the treatment of blood and blood forming organs. | | | BINOCRIT NOVARTIS AG
1400160 18 Jun 2008 | on 09 Jul 2014 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use, namely anticoagulants and platelet aggregation inhibitors; antifibrinolytics; antidotes to anticoagulants and blood; antianaemic preparations; hematological agents. | | | BINOCRIT NOVARTIS AG
1162824 18 Dec 2002 | on 09 Jul 2008 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations human use, namely anticoagulants and platelet aggregation inhibitors; antifibrinolytics; antidotes to anticoagulants, inhibitors and blood; antianaemic preparations; hematological agents. | | 
